TOKYO & MUNICH & BASKING RIDGE, N.J.–(BUSINESS WIRE) January 15,
Read more
Large U.S. Claims Study IDs Complications of COVID-19
TUESDAY, Dec. 8, 2020 — Numerous complications of COVID-19 have
Read moreNurse Practitioners Key to Opioid Treatment in Rural U.S.: Study
THURSDAY, Nov. 26, 2020 — In isolated areas of the
Read morePfizer Update On Our U.S. COVID-19 Vaccine Candidate Distribution Preparedness
NEW YORK, 16 November 2020 — Pfizer (NYSE: PFE) today announced the U.S. COVID-19
Read moreEmergency Sick Leave Helped to Flatten the U.S. COVID-19 Curve
MONDAY, Oct. 19, 2020 — The U.S. emergency sick leave
Read moreU.S. non-English speakers less likely to have SARS-CoV-2 test
(HealthDay)—Non-English speakers are less likely to have completed severe acute
Read moreWatch Elite Powerlifters Take on a U.S. Army Warrior Fitness Workout
As the holder of no less than 25 world records
Read moreHow one patient’s battle with COVID-19 changed U.S. testing protocols
(HealthDay)—The first community-acquired case of COVID-19 in the United States
Read moreWatch This U.S. Marine Take on the U.S. Navy Physical Readiness Test
U.S. Navy sailor Austen Alexander challenged U.S. Marine Sargent Ari
Read moreHorizon Therapeutics plc Announces U.S. FDA Approval of New Dosage Form for Procysbi (Cysteamine Bitartrate) Delayed-Release Oral Granules
DUBLIN–(BUSINESS WIRE)–February 18, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP)
Read more